Issue 9, 2014

An anticancer drug to probe non-specific protein–DNA interactions

Abstract

A visible fluorescence switch of an eminent anti-carcinogen, ellipticine has been used to probe non-specific protein–DNA interaction. The unique pattern of protein–DNA complexation is depicted for the first time through field emission scanning electron microscopy (FE-SEM) images and spectroscopic techniques.

Graphical abstract: An anticancer drug to probe non-specific protein–DNA interactions

Supplementary files

Article information

Article type
Communication
Submitted
18 Oct 2013
Accepted
27 Nov 2013
First published
02 Dec 2013

Phys. Chem. Chem. Phys., 2014,16, 3914-3917

An anticancer drug to probe non-specific protein–DNA interactions

A. Sengupta, R. K. Koninti, K. Gavvala, N. Ballav and P. Hazra, Phys. Chem. Chem. Phys., 2014, 16, 3914 DOI: 10.1039/C3CP54422B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements